Updated Jul 16, 2026
Treace John T. has filed 5 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $1.20M.

John T. Treace is the Chief Executive Officer of Treace Medical Concepts, Inc., a commercial-stage orthopedic medical device company best known for the Lapiplasty 3D Bunion Correction. He has led the company as CEO, overseeing the development, regulatory progress, and commercialization of its bunion correction solutions.
| Role | Insider |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 9.9K | $4.04 | $40K |
| 2026-06-12 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 14.7K | $4.02 | $59K |
| 2026-06-11 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 22.9K | $4.04 | $93K |
| 2026-06-11 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 29.4K | $4.02 | $118K |
| 2026-06-01 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 50.0K | $3.56 | $178K |
| 2026-05-28 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 61.2K | $3.02 | $185K |
| 2026-05-28 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 49.8K | $2.87 | $143K |
| 2026-05-28 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 4.5K | $2.79 | $13K |
| 2026-05-14 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 61.8K | $2.62 | $161K |
| 2026-05-14 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 49.0K | $2.46 | $121K |
| 2026-05-14 | TMCI | TREACE MEDICAL CONCEPTS, INC. | P — Open-market purchase | 43.0K | $2.17 | $93K |
| 2026-03-12 | TMCI | TREACE MEDICAL CONCEPTS, INC. | F — Tax withholding / forfeiture | 5.0K | $0.00 | |
| 2026-03-12 | TMCI | TREACE MEDICAL CONCEPTS, INC. | F — Tax withholding / forfeiture | 2.1K | $0.00 | |
| 2026-01-24 | TMCI | TREACE MEDICAL CONCEPTS, INC. | A — Grant or award | 250.0K | $0.00 | |
| 2026-01-24 | TMCI | TREACE MEDICAL CONCEPTS, INC. | F — Tax withholding / forfeiture | 14.3K | $0.00 | |
| 2026-01-14 | TMCI | TREACE MEDICAL CONCEPTS, INC. | F — Tax withholding / forfeiture | 13.2K | $0.00 |
John T. Treace is the Chief Executive Officer of Treace Medical Concepts, Inc., a commercial-stage orthopedic medical device company best known for the Lapiplasty 3D Bunion Correction. He has led the company as CEO, overseeing the development, regulatory progress, and commercialization of its bunion correction solutions.…
5 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 11 open-market purchases ($1.20M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Treace John T. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.